Tuesday February 10, 2015 0 comments
FORT COLLINS - KromaTiD announced it will partner with France-based tebu-bio to distribute its proprietary dGH and Pinpoint FISH products and services throughout Europe.
Tebu-bio has offices in nine European countries and specializes in supplying innovative life science products and services to the European market.
"We are excited to expand our reach into the European market with a very capable partner," said Alex Vodenlich, KromaTiD's CEO.
"Tebu-bio has been successful in selling and marketing genomics products and services in Europe, and we believe that they are an excellent fit for us."
KromaTiD's commercial offerings include kits and assays for detecting known mutations and for discovering new disease-causing mutations, custom assays for tracking rearrangements to genes and for validating results from sequencing and assays.
"Tebu-bio is excited to add KromaTiD products and services to its growing portfolio of products in the fields of genomics and biomarker discovery," said Mark Livingstone, tebu-bio's head of molecular biology.
"KromaTiD's ability to quickly design and produce custom assays for nearly any chromosomal rearrangement is an innovation that will generate a great deal of interest from our European pharmaceutical customers."